May 22, 2019 | Genetic Analysis, Oncology
Approximately 10% of all colorectal cancers (CRC) are hereditary. Patients who carry a pathogenic germline variant in a CRC-related gene have an increased risk to develop CRC, as well as other cancers. Genetic testing may confirm a diagnosis and help guide treatment...May 22, 2019 | Genetic Analysis, Oncology
Nearly 1 in 6 prostate cancer patients has a germline disease-causing genetic variant. A recent study in JAMA Oncology examining 3607 men with a personal history of prostate cancer has found that 17% had a germline disease-causing genetic variant. This study has...Mar 27, 2019 | Molecular Pathology, Oncology
We are pleased to announce the launch our Next Generation Sequencing panel for Solid tumours (Oncomine Focus assay). This has been done in an attempt to improve and streamline our molecular pathology testing offering. As opposed to testing for single gene anomalies...Oct 30, 2018 | Genetic Analysis, Knowledge Hub, Oncology
PathCare is proud to offer both in-house and international send-away genetic testing for breast and ovarian cancer. Our molecular laboratory offers genetic testing using Sanger and Next Generation Sequencing technologies. We pride ourselves in offering these tests...